| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 03/03/2004 | CN1479723A Method for preparing 4-haloalkyl nicotine nitriles |
| 03/03/2004 | CN1479718A Aryl and heteroarylcyclopropyl oximie ethers and their use as fungicides |
| 03/03/2004 | CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes |
| 03/03/2004 | CN1479618A Treatment of sexual dysfunction using boonbesin antagonist |
| 03/03/2004 | CN1478778A 抗真菌剂及其制备方法和中间体 Antifungal agent and its preparation method and intermediates |
| 03/03/2004 | CN1478771A Synthesis method of substituted pyridine carbamide compound |
| 03/03/2004 | CN1478770A 1,3-dicarbonyl compound and its preparation and use |
| 03/03/2004 | CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor |
| 03/03/2004 | CN1140513C Phenylsulphenyl ureas, process for their preparation and their use as herbicides and plant-growth regulators |
| 03/03/2004 | CA2438909A1 1,4-substituted cyclohexane derivatives |
| 03/03/2004 | CA2400996A1 1,4-substituted cyclohexane derivatives |
| 03/02/2004 | US6699994 Biaryl compounds as serine protease inhibitors |
| 03/02/2004 | US6699993 Treating 2-chloro-(or fluoro-)pyridine with tertiary amine activator and cyanide of hydrogen, ammonium, sodium, potassium, or alkaline earth metal; cyanation |
| 03/02/2004 | US6699990 Colorfastness; waterproofing; oxidative color hair dyes |
| 03/02/2004 | US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims |
| 03/02/2004 | US6699893 Glucocorticoid receptor modulators |
| 03/02/2004 | US6699892 Pharmaceutically acceptable salt of amlodipine and method of preparing the same |
| 03/02/2004 | US6699891 Npyy5 antagonists |
| 03/02/2004 | US6699890 Phosphodiesterase 4 inhibitors |
| 03/02/2004 | US6699878 Imidazonaphthyridines |
| 03/02/2004 | US6699717 Changes in its luminescence lifetime characteristic/intensity as a function of the polarity; a sensor, probe; uses imine ligands to detect presence, amount or concentration of a polar solvent |
| 03/02/2004 | US6699647 Tellurium chemical sensitizers added to the photothermographic emulsion, for example tellurium complexed with four imidazolidin-2-thione groups and two chlorine atoms |
| 03/02/2004 | US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 02/26/2004 | WO2004016597A2 Protein kinase inhibitors and uses thereof |
| 02/26/2004 | WO2004016594A1 Phenylpyridine compound and bactericidal composition containing the same |
| 02/26/2004 | WO2004016593A1 Diaryl compounds as monoamine reuptake inhibitors |
| 02/26/2004 | WO2004016578A2 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 02/26/2004 | WO2004016088A2 Novel 2-pyridylethylbenzamide derivative |
| 02/26/2004 | WO2003101444A8 Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer |
| 02/26/2004 | WO2003097575A3 Amino-functional chalcones |
| 02/26/2004 | WO2003097574A3 Aminoalkoxy-functional chalcones |
| 02/26/2004 | WO2003039549A8 Selective antibacterial agents |
| 02/26/2004 | WO2003006425A9 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| 02/26/2004 | WO2002098869A3 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 02/26/2004 | WO2002094322A3 Combination medicament for treatment of neoplastic diseases containing cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 02/26/2004 | WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 02/26/2004 | WO2002057211A8 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 02/26/2004 | WO2002030902A8 Crystal forms of 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]piperazine.hydrochloride |
| 02/26/2004 | US20040039208 Process for making n-aryl-anthranilic acids and their derivatives |
| 02/26/2004 | US20040039061 Suppress expression and induction of inflammatory cytokines, cell adhesion molecule gene and virus and suppressors for nuclear factor kappa beta (nf-kb) |
| 02/26/2004 | US20040039053 Administering to a patient a (3-halomethylphenoxy) (4-halophenyl) acetic acid derivatives or salt, free of its (+) stereoisomer to treat the type II diabetes, gout, insulin resistance and atherosclerosis |
| 02/26/2004 | US20040039043 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 02/26/2004 | US20040039034 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 02/26/2004 | US20040039029 Thiazolyl urea compounds and methods of uses |
| 02/26/2004 | US20040039028 Nitrogen compounds such as 3,5-dichloro-2-fluoro-4-(3-isoprop -yl-4-methoxyphenoxy)-6-methoxycarbonylmethylaminopyridine, administered for prophylaxis of metabolic disorders |
| 02/26/2004 | US20040039016 HIV protease inhibitors |
| 02/26/2004 | US20040038985 Treating depression, anxiety, obesity, or urinary incontinence |
| 02/26/2004 | US20040038976 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 02/26/2004 | US20040038969 Substituted aminopyrimidines and aminopyridazines; analgesics particularly for migraines, neuropathic pain and associated hyperalgesia and allodynia; antiinflammatory agents; treating asthma, gastrointestinal disorders, etc. |
| 02/26/2004 | US20040038963 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 02/26/2004 | US20040038941 Compounds for the treatment of inflammatory disorders |
| 02/26/2004 | US20040038858 Carboxamide derivatives and their use in the treatment of thromboembolic diseases and tumours |
| 02/26/2004 | US20040037022 Aminoalcohol derivatives |
| 02/26/2004 | CA2495409A1 Diaryl compounds as monoamine reuptake inhibitors |
| 02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
| 02/25/2004 | EP1391456A1 2-iminoimidazole derivative (2) |
| 02/25/2004 | EP1391454A1 Substituted benzamide compounds with antihypertensive activity |
| 02/25/2004 | EP1391451A1 2-iminopyrrolidine derivates |
| 02/25/2004 | EP1391450A1 N-(heterocycle-methyl)alkylamine derivative, process for producing the same, and bactericide |
| 02/25/2004 | EP1391199A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 02/25/2004 | EP1390349A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands |
| 02/25/2004 | EP1390344A2 Organic compounds |
| 02/25/2004 | EP1390342A2 Substituted aromatic amide derivative, intermediate thereof, agrohorticultural insecticide containing thereof and method for the use thereof |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1294662B1 Processes for fluorinating aromatic ring compounds |
| 02/25/2004 | EP1222171B1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 02/25/2004 | EP1181269B1 Cell proliferation inhibitors |
| 02/25/2004 | EP1165064B1 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 02/25/2004 | EP1091648B1 Biocidal composition and its use |
| 02/25/2004 | EP1005446B1 N-aroylphenylalanine derivatives |
| 02/25/2004 | CN1478095A Catalyst composition and method of polymerization |
| 02/25/2004 | CN1478090A Substituted imidazopyridines |
| 02/25/2004 | CN1478078A Nitrogenous aromatic ring compounds |
| 02/25/2004 | CN1478077A Benzamide compounds as APOB secretion inhibitors |
| 02/25/2004 | CN1478076A MCH antagonists and their use in treatment of obesity |
| 02/25/2004 | CN1478072A Tetralone derivatives as antitumor agents |
| 02/25/2004 | CN1477385A Synthesis of 2,6-diaminemethylpyridine derivative fluoescence chemical sensor molecule and its application |
| 02/25/2004 | CN1477099A Ortho-pyridinequinone derivative, composite containing said derivative, its preparation method and application |
| 02/25/2004 | CN1477089A Substituted dicyclohexylalkyl diphenyl derivative with good low-tomp, mutual solubility, its preparation and application |
| 02/25/2004 | CN1139574C Halophenyl pyridyl di-imine transition metal compound and its synthesis process and use |
| 02/25/2004 | CN1139385C Method and composition for lipidization of hydrophilic molecules |
| 02/24/2004 | US6696552 Amidation between primary amine and ester having electron withdrawing functionality; cyclization with keto ester |
| 02/24/2004 | US6696494 α-hydroxyarylbutanamine inhibitors of aspartyl protease |
| 02/24/2004 | US6696487 Fungicidal phenyl(thio)urea and phenyl(thio)carbamate derivatives |
| 02/24/2004 | US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/24/2004 | US6696451 Dihydropyrimidines |
| 02/24/2004 | US6696449 Control degradation of conencting tissue; cardiovascular disorders |
| 02/24/2004 | US6696445 Neuropeptide y receptor antagonists comprising heterocyclic nitrogen compounds and/or prodrugs used for prophylaxis of eating and cardiovascular disorders |
| 02/24/2004 | US6696442 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 02/24/2004 | US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example |
| 02/24/2004 | CA2241887C Process for preparing 2,4-dihydroxypyridine and 2,4-dihydroxy-3-nitropyridine |
| 02/19/2004 | WO2004014871A1 Vanilloid receptor ligands and their use in treatments |
| 02/19/2004 | WO2004014867A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2004014859A2 Process for preparing quinolin antibiotic intermediates |
| 02/19/2004 | WO2004014847A1 Mcp-1 receptor antagonists and method of use thereof |
| 02/19/2004 | WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 02/19/2004 | WO2004014842A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/19/2004 | WO2004014825A1 Cannabinoid receptor ligands |
| 02/19/2004 | WO2004014381A2 Matrix metalloproteinase inhibitors and methods for identification of lead compounds |
| 02/19/2004 | WO2003082190A3 Spirocyclic amides as cannabinoid receptor modulators |